Bloodstream Infection (BSI)
2 clinical trials · Condition
◉ Watch Bloodstream Infection (BSI)
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriaceae Infections (NCT07089186) | Qilu Pharmaceutical Co., Ltd. | 2025-04-12 |
| Prolonged Cardiopulmonary Bypass Time as Predictive Factor for in Hospital Infection (NCT04548167) | University Hospital, Basel, Switzerland | 2020-09-01 |
Track Bloodstream Infection (BSI) automatically
Every clearance here is in the API, with alerts when new ones post.